Inclusion Criteria:  Between the age of 18 and 65. Chronic liver disease (CLD) patients at different stages of liver inflammation (A0-3) and liver fibrosis (F0-4). CLD patients who have indications and are scheduled to undergo liver biopsy.  Exclusion Criteria:  Patients diagnosed with HCC or other types of cancers. Patients who had undergone liver transplantation before enrollment. Any contraindications to either liver biopsy or MRI scan.